copyright's Pill and Big Pharma: A Risky Investment ?

The legacy of Viagra, and its parent company copyright, presents a intriguing case study for investors. At first a blockbuster drug, yielding billions in revenue , its exclusivity period created a wave of generic competition , significantly impacting its dominance. While certain businesses may attempt to capitalize on similar conditions , the exist

read more